The Rise of India's Global Health Diplomacy Amid COVID-19 Pandemic

Overview

Journal Health Promot Perspect

Date 2024 Jan 18

PMID 38235005

Authors

Vijay Kumar Chattu

Bawa Singh

Fnu Kajal

Chakrapani Chatla

Soosanna Kumary Chattu

Sanjay Pattanshetty

K Srikanth Reddy

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic has highlighted the importance of global health diplomacy (GHD), with India emerging as a key player. India's commitment to GHD is demonstrated by its active participation in regional and multilateral projects, pharmaceutical expertise, and large-scale manufacturing capabilities, which include the production and distribution of COVID-19 vaccines and essential medicines. India has supported nations in need through bilateral and multilateral platforms, providing vaccines to countries experiencing shortages and offering technical assistance and capacity-building programs to improve healthcare infrastructure and response capabilities. India's unique approach to GHD, rooted in humanitarian diplomacy, emphasized collaboration and empathy and stressed the well-being of humanity by embracing the philosophy of "Vasudhaiva Kutumbakam," which translates to "." Against this background, this paper's main focus is to analyze the rise of India's GHD amidst the COVID-19 pandemic and its leadership in addressing various global challenges. India has demonstrated its commitment to global solidarity by offering medical supplies, equipment, and expertise to more than 100 countries. India's rising global leadership can be attributed to its proactive approach, humanitarian diplomacy, and significant contributions to global health initiatives.

References

Bollyky T, Gostin L, Hamburg M . The Equitable Distribution of COVID-19 Therapeutics and Vaccines. JAMA. 2020; 323(24):2462-2463. DOI: 10.1001/jama.2020.6641. View

Manu M, Anand G . A review of medical device regulations in India, comparison with European Union and way-ahead. Perspect Clin Res. 2022; 13(1):3-11. PMC: 8815674. DOI: 10.4103/picr.PICR_222_20. View

Singh B, Kaur J, Chattu V . Global vaccine inequities and multilateralism amid COVID-19: Reconnaissance of Global Health Diplomacy as a panacea?. Health Promot Perspect. 2023; 12(4):315-324. PMC: 9958236. DOI: 10.34172/hpp.2022.41. View

Chattu V, Singh B, Kaur J, Jakovljevic M . COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform. Biomed Res Int. 2021; 2021:6658070. PMC: 8416375. DOI: 10.1155/2021/6658070. View

Singh B, Chattu V . Prioritizing 'equity' in COVID-19 vaccine distribution through Global Health Diplomacy. Health Promot Perspect. 2021; 11(3):281-287. PMC: 8501485. DOI: 10.34172/hpp.2021.36. View

Singh B, Chattu V, Kaur J, Mol R, Gauttam P, Singh B . COVID-19 and Global Distributive Justice: 'Health Diplomacy' of India and South Africa for the TRIPS waiver. J Asian Afr Stud. 2023; 58(5):747-765. PMC: 10345817. DOI: 10.1177/00219096211069652. View

Labonte R . Health in All (Foreign) Policy: challenges in achieving coherence. Health Promot Int. 2014; 29 Suppl 1:i48-58. DOI: 10.1093/heapro/dau031. View

Reddy K . India led health innovation(s) for achieving the SDG health goal in the global South. Perspect Public Health. 2022; 142(1):20-21. DOI: 10.1177/17579139211013404. View

Chattu V . The rise of global health diplomacy: An interdisciplinary concept linking health and international relations. Indian J Public Health. 2017; 61(2):134-136. DOI: 10.4103/ijph.IJPH_67_16. View

10.

Riaz M, Ahmad U, Mohan A, Costa A, Khan H, Babar M . Global impact of vaccine nationalism during COVID-19 pandemic. Trop Med Health. 2021; 49(1):101. PMC: 8714455. DOI: 10.1186/s41182-021-00394-0. View

11.

Labonte R, Gagnon M . Framing health and foreign policy: lessons for global health diplomacy. Global Health. 2010; 6:14. PMC: 2936293. DOI: 10.1186/1744-8603-6-14. View

12.

Tatar M, Shoorekchali J, Faraji M, Wilson F . International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis?. J Glob Health. 2021; 11:03086. PMC: 8252691. DOI: 10.7189/jogh.11.03086. View

13.

Kickbusch I, Silberschmidt G, Buss P . Global health diplomacy: the need for new perspectives, strategic approaches and skills in global health. Bull World Health Organ. 2007; 85(3):230-2. PMC: 2636243. DOI: 10.2471/blt.06.039222. View

14.

Kickbusch I . Global health diplomacy: how foreign policy can influence health. BMJ. 2011; 342:d3154. DOI: 10.1136/bmj.d3154. View

15.

Javed S, Chattu V . Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy. Health Promot Perspect. 2020; 10(4):300-305. PMC: 7723006. DOI: 10.34172/hpp.2020.48. View

16.

Fauci A . Lasker Public Service Award. The expanding global health agenda: a welcome development. Nat Med. 2007; 13(10):1169-71. DOI: 10.1038/nm1646. View

17.

Pushkaran A, Chattu V, Narayanan P . A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review. BMJ Glob Health. 2023; 8(10). PMC: 10551961. DOI: 10.1136/bmjgh-2023-012168. View

18.

Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C . A global database of COVID-19 vaccinations. Nat Hum Behav. 2021; 5(7):947-953. DOI: 10.1038/s41562-021-01122-8. View

19.

Chattu V, Singh B, Pattanshetty S, Reddy S . Access to medicines through global health diplomacy. Health Promot Perspect. 2023; 13(1):40-46. PMC: 10257564. DOI: 10.34172/hpp.2023.05. View

20.

Bayati M, Noroozi R, Ghanbari-Jahromi M, Jalali F . Inequality in the distribution of Covid-19 vaccine: a systematic review. Int J Equity Health. 2022; 21(1):122. PMC: 9425802. DOI: 10.1186/s12939-022-01729-x. View